Insights from ASCO GU 2025 l Dr. Kwong Wai Kay, Philip from Hong Kong Integrated Oncology Centre highlights the importance of PSA monitoring, PSMA PET-CT, and HRR testing in managing mHSPC and mCRPC.
Home » Insights from ASCO GU 2025 l Dr. Kwong Wai Kay, Philip from Hong Kong Integrated Oncology Centre highlights the importance of PSA monitoring, PSMA PET-CT, and HRR testing in managing mHSPC and mCRPC.
